VC  Sands Capital

     Office Locations:

1000 Wilson Blvd., Suite 3000
Arlington, VA 22209
Phone: 703-562-4000



  • Early



  • Consumer Products & Services
  • Information Technology
  • Life Sciences & Healthcare



    Sands Capital Ventures invests in promising businesses in three dynamic, high-growth markets: Life Sciences, Technology, and Global Consumer. The firm is the venture capital affiliate of Sands Capital Management, an investment firm founded in 1992 that manages long-only, concentrated public company portfolios.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christy Steele Senior Associate
    Erin Soule CPA Director of Finance and Operations
    Frank Sands CFA CIO and CEO & Co-Founder
    Gene Riechers Venture Partner
    Ian Ratcliffe Managing Partner


    Recent Funding Events (trailing 12 months):







      DiCE Molecules



      Series C





      Series E





      Series E


      Taysha Gene Therapies



      Series B


    Portfolio companies include:

      908 Devices
        web link

        web link

        web link

        web link

      Candel Therapeutics
        web link

        web link

      DiCE Molecules
        web link

      Health Catalyst
        web link

      HUNGRY Marketplace
        web link

      Karuna Pharmaceuticals
        web link

      Kit Check
        web link

      Lending Club
        web link

      Modernizing Medicine
        web link

        web link

        web link

        web link

        web link

        web link

      Taysha Gene Therapies
        web link

        web link

        web link

        web link

        web link


    Recent News: